Abstract:Cytochrome P450scc (CYP11A1) can hydroxylate vitamin D3 producing 20S-hydroxyvitamin D3 [20(OH)D3] and 20S,23-dihydroxyvitamin D3 [20,23(OH)2D3] as the major metabolites. These are biologically active acting as partial vitamin D receptor [VDR] agonists. Minor products include 17-hydroxyvitamin D3, 17,20-dihydroxyvitamin D3 and 17,20,23trihydroxyvitamin D3. In the current study we have further analyzed the reaction products from P450scc action on vitamin D3 and have identified two 22-hydroxy-derivatives as products, 22hydroxyvitamin D3 [22(OH)D3] and 20S,22-dihydroxyvitamin D3 [20,22(OH)2D3]. The structures of both of these derivatives were determined by NMR. P450scc could convert purified 22(OH)D3 to 20,22(OH)2D3. The 20,22(OH)2D3 could also be produced from 20(OH)D3 and was metabolized to a trihydroxyvitamin D3 product. We compared the biological activities of these new derivatives to those of 20(OH)D3, 20,23(OH)2D3 and 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3]. 1,25(OH)2D3, 20(OH)D3, 22(OH)D3, 20,23(OH)2D3 and 20,22(OH)2D3 significantly inhibited keratinocyte proliferation in a dose dependent manner. The strongest inducers of involucrin expression (a marker of keratinocyte differentiation) were 20,23(OH)2D3, 20,22(OH)2D3, 20(OH)D3 and 1,25(OH)2D3, with 22(OH)D3 having a heterogeneous effect. Little or no stimulation of CYP24 mRNA expression was observed for all the analogues tested except for 1,25(OH)2D3. All the compounds stimulated VDR translocation from the cytoplasm to the nucleus with 22(OH)D3 and 20,22(OH)2D3 having less effect than 1,25(OH)2D3 and 20(OH)D3. Thus we have identified 22(OH)D3 and 20,22(OH)2D3 as products of CYP11A1 action on vitamin D3 and shown that like 20(OH)D3 and 20,23(OH)2D3, they are active on keratinocytes via the VDR, however, showing a degree of phenotypic heterogeneity in comparison to other P450scc-derived hydroxy-metabolites of vitamin D3. DMD #40071 This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on June 15, 2011 as DOI: 10.1124/dmd.111.040071 at A PE T Jornals on M arch 6, 2022 dm d.aspurnals.org D ow nladed from

In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland.

In Vivo Evidence for A Novel Pathway of Vitamin D-3 Metabolism Initiated by P450scc and Modified by Cyp27b1

Production of 22-hydroxy metabolites of vitamin d3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells.

Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland

Chemical synthesis, biological activities and action on nuclear receptors of 20S(OH)D3, 20S,25(OH)2D3, 20S,23S(OH)2D3 and 20S,23R(OH)2D3

Ultra-high-performance Liquid Chromatography-Tandem Mass Spectrometry Analysis of Serum Metabolomic Characteristics in People with Different Vitamin D Levels

Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1.

Microsoft Word-31088317-file00

Novel vitamin D analogs as potential therapeutics: metabolism, toxicity profiling, and antiproliferative activity.

Metabolic activation of tachysterol3 to biologically active hydroxyderivatives that act on VDR, AhR, LXRs, and PPARγ receptors

20-Hydroxyvitamin D2 is a Noncalcemic Analog of Vitamin D with Potent Antiproliferative and Prodifferentiation Activities in Normal and Malignant Cells.

4-Hydroxy-1α,25-Dihydroxyvitamin D3: Synthesis and Structure–Function Study

Synthesis and Biological Evaluation of Vitamin D3 Metabolite 20S,23s-Dihydroxyvitamin D3 and Its 23r Epimer

1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor

Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts

Discovery and Structural Analysis of Metabolites of Vitamin D3 Lactones

Chemical Synthesis and Biological Activities of 20S,24s/r-Dihydroxyvitamin D3 Epimers and Their 1Α-Hydroxyl Derivatives

Biological Effects of CYP11A1-Derived Vitamin D and Lumisterol Metabolites in the Skin

The Mechanism of 1,25-Dihydroxyvitamin D(3) Autoregulation in Keratinocytes.

26,27-Dihomo-1 alpha-hydroxy- and 26,27-dihomo-24-epi-1 alpha,25-dihydroxyvitamin D2 analogs that differ markedly in biological activity in vivo.

New Metabolic Pathway of (24R)-24,25-dihydroxyvitamin D3: Epimerization of the 3-Hydroxy Group.